Feb 03, 2021
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020
Jan 22, 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Jan 14, 2021
Boston Scientific Launches WaveWriter Alpha(TM) Spinal Cord Stimulator Systems In U.S.
Jan 12, 2021
Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year 2020
Dec 14, 2020
Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California
Dec 01, 2020
Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business
Nov 23, 2020
Boston Scientific to Participate in Evercore ISI 2020 Healthcare Conference
Nov 17, 2020
Boston Scientific Announces LOTUS Edge(TM) Aortic Valve System Voluntary Recall and Product Discontinuation
Nov 05, 2020
Boston Scientific Announces November 2020 Conference Schedule
Nov 02, 2020
Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-Coated Balloon
Oct 29, 2020
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Oct 28, 2020
Boston Scientific Announces Results For Third Quarter 2020
Oct 01, 2020
Boston Scientific Announces Transcatheter Cardiovascular Therapeutics 2020 Investor Update and Conference Call Discussing Third Quarter 2020 Results
Sep 30, 2020
Boston Scientific Launches WaveWriter Alpha(TM) Spinal Cord Stimulator Systems In Europe
Sep 21, 2020
Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
Sep 09, 2020
Boston Scientific Launches Vercise Genus(TM) DBS System In Europe
Aug 26, 2020
Boston Scientific Announces September 2020 Conference Schedule
Jul 29, 2020
Boston Scientific Announces Results For Second Quarter 2020
Jul 21, 2020
Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device
Jun 30, 2020
Boston Scientific Announces Conference Call Discussing Second Quarter 2020 Financial Results